Small-molecule anti-COVID-19 drugs and a focus on China’s homegrown mindeudesivir (VV116)
Qiuyu Cao, Yi Ding, Yu Xu, Mian Li, Ruizhi Zheng, Zhujun Cao, Weiqing Wang, Yufang Bi, Guang Ning, Yiping Xu, Ren Zhao
Topics & Concepts
RitonavirCoronavirus disease 2019 (COVID-19)TolerabilityMedicinePandemicSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)CoronavirusIntensive care medicineDrug2019-20 coronavirus outbreakPharmacologyDiseaseVirologyInfectious disease (medical specialty)Adverse effectInternal medicineHuman immunodeficiency virus (HIV)Viral loadAntiretroviral therapyOutbreakCOVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 ResearchPharmacological Receptor Mechanisms and Effects